Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC53H68ClN9O12S |
InChIKeyQTBMHRVZWBBKIB-UHFFFAOYSA-N |
CAS Registry2290504-90-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 15 Jul 2019 |